Quantity of qualified sufferers: CDEC mentioned the uncertainty in the amount of clients with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some sufferers who will be categorized as having gentle or average ailment may have a significant bleeding https://hemgenix95937.is-blog.com/42394551/not-known-details-about-hemgenix